Published in Gene Therapy Weekly, October 7th, 1996
Kimeragen has been developing chimeraplasty as a potential treatment for genetic diseases, cancer and viral diseases. PE Applied Biosystems and Kimeragen also make the chimeric compounds available for non-profit academic research through PE Applied Biosystems' custom oligonucleotide synthesis service.
Chimeraplasty is a gene repair technology designed to correct genetic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.